Shandong Luning Pharmaceutical

Shandong Luning Pharmaceutical is a Chinese pharmaceutical enterprise established in 1993 and headquartered in Jining, Shandong Province. The company specializes in the development and large-scale manufacturing of chemical pharmaceuticals and Traditional Chinese Medicines (TCM) across multiple dosage forms, including tablets, capsules, and granules. Its product portfolio focuses heavily on urology, cardiovascular health, and respiratory ailments, with Tamsulosin Hydrochloride serving as a key commercial product for treating benign prostatic hyperplasia. Shandong Luning operates as a certified high-tech enterprise, maintaining GMP-compliant facilities and a robust distribution network throughout China. The company's business model integrates R&D, production, and sales to deliver both modern chemical drugs and refined traditional remedies.